Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

FDA Questions Effectiveness of Weight Loss Pill

December 3, 2010 7:15 am | by Matthew Perrone | News | Comments

The Food and Drug Administration says a pill to treat obesity from Orexigen Therapeutics Inc. helped patients lose weight, though it didn't meet all the criterion set forth by the agency.

TOPICS:

Researchers Discover Life Built with Arsenic

December 3, 2010 7:13 am | News | Comments

Researchers conducting tests in the harsh environment of Mono Lake in California have discovered the first known microorganism on Earth able to thrive and reproduce using the toxic chemical arsenic.

TOPICS:

Positive Recommendation on AstraZeneca Cancer Drug

December 3, 2010 7:10 am | News | Comments

AstraZeneca PLC said December 2 that a Food and Drug Administration panel made a positive recommendation on vandetanib, a drug the company is developing as a treatment for a rare type of thyroid cancer.

TOPICS:
Advertisement

Microscopy Captures Video of Blood Cell Movement

December 3, 2010 6:43 am | by Steve Bradt, Harvard Staff Writer | News | Comments

A novel type of biomedical imaging, made possible by new advances in microscopy from scientists at Harvard University, is so fast and sensitive it can capture "video" of blood cells squeezing through capillaries.

TOPICS:

Biomarkers Could Test Huntington's Disease Treatments

December 3, 2010 6:40 am | News | Comments

A range of new clinical, functional, and neuroimaging tests make it possible to track the progression of Huntington's disease (HD) long before noticeable symptoms appear.

TOPICS:

Assay Methods for Biochrom Microplate Readers

December 3, 2010 6:38 am | Product Releases | Comments

Biochrom Ltd announces increased functionality in its microplate readers that now enable users of GE Healthcare’s Biotrak range of immunoassay kits to download pre-programmed method definitions.

TOPICS:

96-well Screening Plates

December 2, 2010 7:22 am | Product Releases | Comments

Biotage offers the ExploraSep 96-well screening plates to identify optimum scavengers.

TOPICS:

Low Profile 96-well Microplate

December 2, 2010 7:17 am | Product Releases | Comments

Porvair Sciences Ltd has announced a low profile 96-well microplate designed to minimize the space required for compound storage.

TOPICS:
Advertisement

Findings Detail How Virus Prepares to Infect Cells

December 2, 2010 7:08 am | by Emil Venere | News | Comments

Researchers have learned the atomic-scale arrangement of proteins in a structure that enables a virus to invade and fuse with host cells, showing precisely how the structure morphs with changing acidity to initiate infection.

TOPICS:

Drug-like Compound Stops Thyroid Overstimulation

December 2, 2010 7:05 am | News | Comments

Researchers at the National Institutes of Health (NIH) have identified a compound that prevents overproduction of thyroid hormone, a finding that brings scientists one step closer to improving treatment for Graves' disease.

TOPICS:

Centralized Reporting for Lab Informatics

December 2, 2010 7:01 am | Product Releases | Comments

Labtronics Inc. announced the release of Nexxis RM, a reporting tool that centralizes the reporting for all lab informatics systems into one central location.

TOPICS:

Cell Sorter

December 2, 2010 6:59 am | Product Releases | Comments

The MoFlo Astrios next-generation cell sorter from Beckman Coulter, Inc. features the fluidic design of the original MoFlo and the electronic processing of the MoFlo XDP.

TOPICS:

Patheon Announces Leadership Change

December 2, 2010 6:53 am | News | Comments

Patheon announced that Wesley P. Wheeler, the company's chief executive officer and president, has left the company. Peter Bigelow has been named interim chief executive officer.

TOPICS:

Harvard Bioscience Licenses Cellectis Electroporation Instruments

December 2, 2010 6:47 am | News | Comments

Cellectis and Harvard Apparatus signed a license agreement that grants Harvard Apparatus the worldwide exclusive right to manufacture and sell, for research use, a line of electroporation-based instruments.

TOPICS:

FDA Panel Rejects Drugs to Prevent Prostate Cancer

December 2, 2010 6:42 am | by Matthew Perrone, AP Health Writer | News | Comments

A panel of federal health experts rejected the use of two drugs from Merck and GlaxoSmithKline to prevent prostate cancer, saying the drugs could actually raise the risk of the most serious types of tumors.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading